Nanoscale theranostics for physical stimulus-responsive cancer therapies

Biomaterials

Volumn 73, Issue , 2015, Pages 214-230

  Chen, Qian ^a   Ke, Hengte ^b   Dai, Zhifei ^c   Liu, Zhuang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Cancer therapies; Physical stimulus; Theranostics

Indexed keywords

CHEMOTHERAPY; DISEASES; NANOTECHNOLOGY; ONCOLOGY;

ANIMAL EXPERIMENTS; CANCER CHEMOTHERAPY; CANCER THERAPY; MULTIFUNCTIONAL THERANOSTIC AGENTS; PHYSICAL STIMULUS; THERANOSTIC AGENTS; THERAPEUTIC STRATEGY; TOXIC SIDE EFFECTS;

THERANOSTICS;

DYE; ANTINEOPLASTIC AGENT; BIOMATERIAL; CONTRAST MEDIUM; NANOPARTICLE;

CANCER THERAPY; HYPERTHERMIC THERAPY; IONIZING RADIATION; MAGNETIC FIELD; MAGNETOTHERAPY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PHYSICAL STIMULUS RESPONSIVE THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; STIMULATION; THERANOSTICS; TREATMENT RESPONSE; ULTRASOUND THERAPY; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; LIGHT; MAGNETISM; MOUSE; MULTIMODALITY CANCER THERAPY; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES; TEMPERATURE; THERANOSTIC NANOMEDICINE; ULTRASOUND;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; COMBINED MODALITY THERAPY; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; LIGHT; MAGNETICS; MICE; NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; TEMPERATURE; THERANOSTIC NANOMEDICINE; ULTRASONICS;

EID: 84943558849     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.09.018     Document Type: Review

References (234)

1. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5:161-171.
2. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
3. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 2007, 13:1050-1059.
4. Goldberg S.N., Kamel I.R., Kruskal J.B., Reynolds K., Monsky W.L., Stuart K.E., et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am. J. Roentgenol. 2002, 179:93-101.
5. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discovery 2005, 4:255-260.
6. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv. Drug Delivery Rev. 2008, 60:1153-1166.
7. Hirsch L.R., Stafford R., Bankson J., Sershen S., Rivera B., Price R., et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. 2003, 100:13549-13554.
8. Mornet S., Vasseur S., Grasset F., Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 2004, 14:2161-2175.
9. Kumar C.S., Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Delivery Rev. 2011, 63:789-808.
10. Wang C., Tao H., Cheng L., Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
11. Wu G., Mikhailovsky A., Khant H.A., Fu C., Chiu W., Zasadzinski J.A. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J. Am. Chem. Soc. 2008, 130:8175-8177.
12. Huang P., Lin J., Wang X., Wang Z., Zhang C., He M., et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv. Mater. 2012, 24:5104-5110.
13. Bown S. Phototherapy of tumors. World J. Surg. 1983, 7:700-709.
14. Cheng L., Wang C., Feng L., Yang K., Liu Z. Functional nanomaterials for phototherapies of cancer. Chem. Rev. 2014, 114:10869-10939.
15. Sahu A., Choi W.I., Lee J.H., Tae G. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials 2013, 34:6239-6248.
16. Mikhaylov G., Mikac U., Magaeva A.A., Itin V.I., Naiden E.P., Psakhye I., et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat. Nanotechnol. 2011, 6:594-602.
17. Lentacker I., Geers B., Demeester J., De Smedt S.C., Sanders N.N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol. Ther. 2010, 18:101-108.
18. Raoof M., Corr S.J., Kaluarachchi W.D., Massey K.L., Briggs K., Zhu C., et al. Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy. Nanomed. Nanotechnol. 2012, 8:1096-1105.
19. Sawada N., Ishikawa T., Sekiguchi F., Tanaka Y., Ishitsuka H. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin. Cancer Res. 1999, 5:2948-2953.
20. Bardhan R., Lal S., Joshi A., Halas N.J. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc. Chem. Res. 2011, 44:936-946.
21. Janib S.M., Moses A.S., MacKay J.A. Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Delivery Rev. 2010, 62:1052-1063.
22. Kelkar S.S., Reineke T.M. Theranostics: combining imaging and therapy. Bioconjug Chem. 2011, 22:1879-1903.
23. Yang K., Zhang S., Zhang G., Sun X., Lee S.-T., Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010, 10:3318-3323.
24. Huang X., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 2006, 128:2115-2120.
25. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., et al. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90:889-905.
26. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 2009, 38:372-390.
27. Tian Q., Tang M., Sun Y., Zou R., Chen Z., Zhu M., et al. Hydrophilic flower-like CuS superstructures as an efficient 980 nm laser-driven photothermal agent for ablation of cancer cells. Adv. Mater. 2011, 23:3542-3547.
28. Huang X., Tang S., Mu X., Dai Y., Chen G., Zhou Z., et al. Freestanding palladium nanosheets with plasmonic and catalytic properties. Nat. Nanotechnol. 2011, 6:28-32.
29. Dykman L., Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem. Soc. Rev. 2012, 41:2256-2282.
30. Navarro J.R., Manchon D., Lerouge F., Blanchard N.P., Marotte S., Leverrier Y., et al. Synthesis of PEGylated gold nanostars and bipyramids for intracellular uptake. Nanotechnology 2012, 23:465602.
31. Liu Z., Robinson J.T., Sun X., Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 2008, 130:10876-10877.
32. Kim J.-W., Galanzha E.I., Shashkov E.V., Moon H.-M., Zharov V.P. Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents. Nat. Nanotechnol. 2009, 4:688-694.
33. Cheng L., Liu J., Gu X., Gong H., Shi X., Liu T., et al. PEGylated WS2 nanosheets as a multifunctional theranostic agent for in vivo dual-Modal CT/Photoacoustic imaging guided photothermal therapy. Adv. Mater. 2014, 26:1886-1893.
34. Chen Z., Wang Q., Wang H., Zhang L., Song G., Song L., et al. Ultrathin PEGylated W18O49 nanowires as a new 980 nm-laser-driven photothermal agent for efficient ablation of cancer cells in vivo. Adv. Mater. 2013, 25:2095-2100.
35. Liu T., Wang C., Gu X., Gong H., Cheng L., Shi X., et al. Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer. Adv. Mater. 2014, 26:3433-3440.
36. Chu M., Pan X., Zhang D., Wu Q., Peng J., Hai W. The therapeutic efficacy of CdTe and CdSe quantum dots for photothermal cancer therapy. Biomaterials 2012, 33:7071-7083.
37. Li W., Zamani R., Rivera Gil P., Pelaz B., Ibáñez M., Cadavid D., et al. CuTe nanocrystals: shape and size control, plasmonic properties, and use as SERS probes and photothermal agents. J. Am. Chem. Soc. 2013, 135:7098-7101.
38. Yang K., Xu H., Cheng L., Sun C., Wang J., Liu Z. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv. Mater. 2012, 24:5586-5592.
39. Cheng L., Yang K., Chen Q., Liu Z. Organic stealth nanoparticles for highly effective in vivo near-infrared photothermal therapy of cancer. ACS Nano 2012, 6:5605-5613.
40. Song X., Chen Q., Liu Z. Recent advances in the development of organic photothermal nano-agents. Nano Res. 2014, 1-15.
41. Lovell J.F., Jin C.S., Huynh E., Jin H., Kim C., Rubinstein J.L., et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 2011, 10:324-332.
42. Ma Y., Tong S., Bao G., Gao C., Dai Z. Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy. Biomaterials 2013, 34:7706-7714.
43. Gao F.-P., Lin Y.-X., Li L.-L., Liu Y., Mayerhöffer U., Spenst P., et al. Supramolecular adducts of squaraine and protein for noninvasive tumor imaging and photothermal therapy in vivo. Biomaterials 2014, 35:1004-1014.
44. Zhen Z., Tang W., Guo C., Chen H., Lin X., Liu G., et al. Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer. ACS Nano 2013, 7:6988-6996.
45. Cheng L., He W., Gong H., Wang C., Chen Q., Cheng Z., et al. PEGylated micelle nanoparticles encapsulating a non-fluorescent near-infrared organic dye as a safe and highly-effective photothermal agent for in vivo cancer therapy. Adv. Funct. Mater. 2013, 23:5893-5902.
46. Boisselier E., Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 2009, 38:1759-1782.
47. Chen Q., Wang C., Zhan Z., He W., Cheng Z., Li Y., et al. Near-infrared dye bound albumin with separated imaging and therapy wavelength channels for imaging-guided photothermal therapy. Biomaterials 2014, 35:8206-8214.
48. Chen Q., Liang C., Wang X., He J., Li Y., Liu Z. An albumin-based theranostic nano-agent for dual-modal imaging guided photothermal therapy to inhibit lymphatic metastasis of cancer post surgery. Biomaterials 2014, 35:9355-9362.
49. Zha Z., Wang J., Zhang S., Wang S., Qu E., Zhang Y., et al. Engineering of perfluorooctylbromide polypyrrole nano-/microcapsules for simultaneous contrast enhanced ultrasound imaging and photothermal treatment of cancer. Biomaterials 2014, 35:287-293.
50. Yang K., Hu L., Ma X., Ye S., Cheng L., Shi X., et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv. Mater. 2012, 24:1868-1872.
51. De La Zerda A., Zavaleta C., Keren S., Vaithilingam S., Bodapati S., Liu Z., et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat. Nanotechnol. 2008, 3:557-562.
52. Cheng L., Liu J., Gu X., Gong H., Shi X., Liu T., et al. Imaging: PEGylated WS2 nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/Photoacoustic imaging guided photothermal therapy. Adv. Mater. 2014, 26:1794.
53. Wang C., Ma X., Ye S., Cheng L., Yang K., Guo L., et al. Protamine functionalized single-walled carbon nanotubes for stem cell labeling and in vivo raman/magnetic resonance/photoacoustic triple-modal imaging. Adv. Funct. Mater. 2012, 22:2363-2375.
54. Li Z., Yin S., Cheng L., Yang K., Li Y., Liu Z. Magnetic targeting enhanced theranostic strategy based on multimodal imaging for selective ablation of cancer. Adv. Funct. Mater. 2013, 24:2312-2321.
55. Gong H., Dong Z., Liu Y., Yin S., Cheng L., Xi W., et al. Engineering of multifunctional nano-micelles for combined photothermal and photodynamic therapy under the guidance of multimodal imaging. Adv. Funct. Mater. 2014, 24:6492-6502.
56. Xu M., Wang L.V. Photoacoustic imaging in biomedicine. Rev. Sci. Instrum. 2006, 77:041101.
57. Chen Q., Liang C., Wang X., He J., Li Y., Liu Z. An albumin-based theranostic nano-agent for dual-modal imaging guided photothermal therapy to inhibit lymphatic metastasis of cancer post surgery. Biomaterials 2014, 35:9355-9362.
58. Deng R., Xie X., Vendrell M., Chang Y.-T., Liu X. Intracellular glutathione detection using MnO2-nanosheet-modified upconversion nanoparticles. J. Am. Chem. Soc. 2011, 133:20168-20171.
59. Cheng L., Yang K., Li Y., Chen J., Wang C., Shao M., et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew. Chem. Int. Ed. 2011, 123:7523-7528.
60. Ji X., Shao R., Elliott A.M., Stafford R.J., Esparza-Coss E., Bankson J.A., et al. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy. J. Phys. Chem. C 2007, 111:6245-6251.
61. MacDonald T.D., Liu T.W., Zheng G. An MRI-Sensitive, Non-photobleachable porphysome photothermal agent. Angew. Chem. Int. Ed. 2014, 126:7076-7079.
62. Wang L., Luo J., Fan Q., Suzuki M., Suzuki I.S., Engelhard M.H., et al. Monodispersed core-shell Fe3O4 at Au nanoparticles. J. Phys. Chem. B 2005, 109:21593-21601.
63. Xu Z., Hou Y., Sun S. Magnetic core/shell Fe3O4/Au and Fe3O4/Au/Ag nanoparticles with tunable plasmonic properties. J. Am. Chem. Soc. 2007, 129:8698-8699.
64. Tian Q., Hu J., Zhu Y., Zou R., Chen Z., Yang S., et al. Sub-10 nm Fe3O4 at Cu2-x S core-shell nanoparticles for dual-modal imaging and photothermal therapy. J. Am. Chem. Soc. 2013, 135:8571-8577.
65. Choi J.H., Nguyen F.T., Barone P.W., Heller D.A., Moll A.E., Patel D., et al. Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett. 2007, 7:861-867.
66. Liang X., Li Y., Li X., Jing L., Deng Z., Yue X., et al. PEGylated polypyrrole nanoparticles conjugating gadolinium chelates for dual-modal MRI/photoacoustic imaging guided photothermal therapy of cancer. Adv. Funct. Mater. 2015, 25:1451-1462.
67. Liu T., Shi S., Liang C., Shen S., Cheng L., Wang C., et al. Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-Free radiolabeling and multimodal imaging guided photothermal therapy. ACS Nano 2015, 9:950-960.
68. Zhou M., Zhang R., Huang M., Lu W., Song S., Melancon M.P., et al. A chelator-free multifunctional [64Cu] CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J. Am. Chem. Soc. 2010, 132:15351-15358.
69. Kim D., Jeong Y.Y., Jon S. A drug-loaded aptamer- gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 2010, 4:3689-3696.
70. Huang P., Bao L., Zhang C., Lin J., Luo T., Yang D., et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 2011, 32:9796-9809.
71. Zhang X.D., Chen J., Min Y., Park G.B., Shen X., Song S.S., et al. Metabolizable Bi2Se3 nanoplates: biodistribution, toxicity, and uses for cancer radiation therapy and imaging. Adv. Funct. Mater. 2014, 24:1718-1729.
72. Ke H., Wang J., Tong S., Jin Y., Wang S., Qu E., et al. Gold nanoshelled liquid perfluorocarbon magnetic nanocapsules: a nanotheranostic platform for bimodal ultrasound/magnetic resonance imaging guided photothermal tumor ablation. Theranostics 2014, 4:12-23.
73. Ke H., Wang J., Dai Z., Jin Y., Qu E., Xing Z., et al. Gold-nanoshelled Microcapsules: A theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew. Chem. Int. Ed. 2011, 123:3073-3077.
74. Liu T.W., MacDonald T.D., Jin C.S., Gold J.M., Bristow R.G., Wilson B.C., et al. Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases. ACS Nano 2013, 7:4221-4232.
75. Chen J., Glaus C., Laforest R., Zhang Q., Yang M., Gidding M., et al. Gold nanocages as photothermal transducers for cancer treatment. Small 2010, 6:811-817.
76. Fang C., Zhang M. Multifunctional magnetic nanoparticles for medical imaging applications. J. Mater. Chem. 2009, 19:6258-6266.
77. Chen H., Zhang X., Dai S., Ma Y., Cui S., Achilefu S., et al. Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy. Theranostics 2013, 3:633-649.
78. Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3:380-387.
79. Sharman W.M., Allen C.M., Van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discovery today 1999, 4:507-517.
80. Hota R., Baek K., Yun G., Kim Y., Jung H., Park K.M., et al. Self-assembled, covalently linked, hollow phthalocyanine nanospheres. Chem. Sci. 2013, 4:339-344.
81. Bédard M.F., Sadasivan S., Sukhorukov G.B., Skirtach A. Assembling polyelectrolytes and porphyrins into hollow capsules with laser-responsive oxidative properties. J. Mater. Chem. 2009, 19:2226-2233.
82. Nishiyama N., Nakagishi Y., Morimoto Y., Lai P.-S., Miyazaki K., Urano K., et al. Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. J. Controlled Release 2009, 133:245-251.
83. Peng C.-L., Shieh M.-J., Tsai M.-H., Chang C.-C., Lai P.-S. Self-assembled star-shaped chlorin-core poly (e{open}-caprolactone)-poly (ethylene glycol) diblock copolymer micelles for dual chemo-photodynamic therapies. Biomaterials 2008, 29:3599-3608.
84. Liang X., Li X., Jing L., Yue X., Dai Z. Theranostic porphyrin dyad nanoparticles for magnetic resonance imaging guided photodynamic therapy. Biomaterials 2014, 35:6379-6388.
85. Liang X., Li X., Yue X., Dai Z. Conjugation of porphyrin to nanohybrid cerasomes for photodynamic diagnosis and therapy of cancer. Angew. Chem. Int. Ed. 2011, 123:11826-11831.
86. Tsay J.M., Trzoss M., Shi L., Kong X., Selke M., Jung M.E., et al. Singlet oxygen production by peptide-coated quantum dot-photosensitizer conjugates. J. Am. Chem. Soc. 2007, 129:6865-6871.
87. 2 Core/Shell Nanoparticles: a facile three-in-One system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. Small 2008, 4:218-224.
88. Khaing Oo M.K., Yang Y., Hu Y., Gomez M., Du H., Wang H. Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX. ACS Nano 2012, 6:1939-1947.
89. Cheng Y., Samia A C., Meyers J.D., Panagopoulos I., Fei B., Burda C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc. 2008, 130:10643-10647.
90. Ohulchanskyy T.Y., Roy I., Goswami L.N., Chen Y., Bergey E.J., Pandey R.K., et al. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett. 2007, 7:2835-2842.
91. Vivero-Escoto J.L., Huxford-Phillips R.C., Lin W. Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem. Soc. Rev. 2012, 41:2673-2685.
92. Yang G., Gong H., Qian X., Tan P., Li Z., Liu T., et al. Mesoporous silica nanorods intrinsically doped with photosensitizers as a multifunctional drug carrier for combination therapy of cancer. Nano Res. 2014, 8:751-764.
93. 2 (B)/anatase nanofibers for killing of HeLa cells. Nano Res. 2014, 7:1659-1669.
94. Tian B., Wang C., Zhang S., Feng L., Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011, 5:7000-7009.
95. Wang C., Cheng L., Liu Y., Wang X., Ma X., Deng Z., et al. Imaging-guided pH-sensitive photodynamic therapy using charge reversible upconversion nanoparticles under near-infrared light. Adv. Funct. Mater. 2013, 23:3077-3086.
96. Chen Q., Wang C., Cheng L., He W., Cheng Z., Liu Z. Protein modified upconversion nanoparticles for imaging-guided combined photothermal and photodynamic therapy. Biomaterials 2014, 35:2915-2923.
97. Liu K., Liu X., Zeng Q., Zhang Y., Tu L., Liu T., et al. Covalently assembled NIR nanoplatform for simultaneous fluorescence imaging and photodynamic therapy of cancer cells. ACS Nano 2012, 6:4054-4062.
98. Chen Q., Wang X., Wang C., Feng L., Li Y., Liu Z. Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy. ACS Nano 2015, 9:5223-5233.
99. Wöhrle D., Wendt A., Weitemeyer A., Stark J., Spiller W., Schneider G., et al. Metal chelates of porphyrin derivatives as sensitizers in photooxidation processes of sulfur compounds and in photodynamic therapy of cancer. Russ. Chem. B 1994, 43:1953-1964.
100. Hansson M.D., Karlberg T., Rahardja M.A., Al-Karadaghi S., Hansson M. Amino acid residues His183 and Glu264 in Bacillus subtilis ferrochelatase direct and facilitate the insertion of metal ion into protoporphyrin IX. Biochemistry 2007, 46:87-94.
101. Jin C.S., Cui L., Wang F., Chen J., Zheng G. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy. Adv. Healthcare Mater. 2014, 3:1240-1249.
102. Jin C.S., Lovell J.F., Chen J., Zheng G. Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano 2013, 7:2541-2550.
103. Cao Z., Ma Y., Yue X., Li S., Dai Z., Kikuchi J. Stabilized liposomal nanohybrid cerasomes for drug delivery applications. Chem. Commun. 2010, 46:5265-5267.
104. Zhou J., Liu Z., Li F. Upconversion nanophosphors for small-animal imaging. Chem. Soc. Rev. 2012, 41:1323-1349.
105. Zhang P., Steelant W., Kumar M., Scholfield M. Versatile photosensitizers for photodynamic therapy at infrared excitation. J. Am. Chem. Soc. 2007, 129:4526-4527.
106. Park Y.I., Kim H.M., Kim J.H., Moon K.C., Yoo B., Lee K.T., et al. Theranostic probe based on lanthanide-doped nanoparticles for simultaneous in vivo dual-modal imaging and photodynamic therapy. Adv. Mater. 2012, 24:5755-5761.
107. Wang F., Deng R., Wang J., Wang Q., Han Y., Zhu H., et al. Tuning upconversion through energy migration in core-shell nanoparticles. Nat. Mater. 2011, 10:968-973.
108. Idris N.M., Gnanasammandhan M.K., Zhang J., Ho P.C., Mahendran R., Zhang Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat. Med. 2012, 18:1580-1585.
109. Kumar R., Nyk M., Ohulchanskyy T.Y., Flask C.A., Prasad P.N. Combined optical and MR bioimaging using rare earth ion doped NaYF4 nanocrystals. Adv. Funct. Mater. 2009, 19:853-859.
110. Zhou J., Yu M., Sun Y., Zhang X., Zhu X., Wu Z., et al. Fluorine-18-labeled Gd 3+/Yb 3+/Er 3+ co-doped NaYF 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
111. Xing H., Bu W., Zhang S., Zheng X., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
112. Wu Y., Sun Y., Zhu X., Liu Q., Cao T., Peng J., et al. Lanthanide-based nanocrystals as dual-modal probes for SPECT and X-ray CT imaging. Biomaterials 2014, 35:4699-4705.
113. Cao T., Yang Y., Sun Y., Wu Y., Gao Y., Feng W., et al. Biodistribution of sub-10 nm PEG-modified radioactive/upconversion nanoparticles. Biomaterials 2013, 34:7127-7134.
114. Peng J., Sun Y., Zhao L., Wu Y., Feng W., Gao Y., et al. Polyphosphoric acid capping radioactive/upconverting NaLuF 4: Yb, Tm, 153 Sm nanoparticles for blood pool imaging in vivo. Biomaterials 2013, 34:9535-9544.
115. Sun Y., Liu Q., Peng J., Feng W., Zhang Y., Yang P., et al. Radioisotope post-labeling upconversion nanophosphors for in vivo quantitative tracking. Biomaterials 2013, 34:2289-2295.
116. Sun Y., Yu M., Liang S., Zhang Y., Li C., Mou T., et al. Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. Biomaterials 2011, 32:2999-3007.
117. Kang H., Trondoli A.C., Zhu G., Chen Y., Chang Y.-J., Liu H., et al. Near-infrared light-responsive core-shell nanogels for targeted drug delivery. ACS Nano 2011, 5:5094-5099.
118. Ma M., Chen H., Chen Y., Wang X., Chen F., Cui X., et al. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging. Biomaterials 2012, 33:989-998.
119. Zheng M., Yue C., Ma Y., Gong P., Zhao P., Zheng C., et al. Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano 2013, 7:2056-2067.
120. Zhang W., Guo Z., Huang D., Liu Z., Guo X., Zhong H. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 2011, 32:8555-8561.
121. Liu J., Wang C., Wang X., Wang X., Cheng L., Li Y., et al. Mesoporous silica coated single-walled carbon nanotubes as a multifunctional light-responsive platform for cancer combination therapy. Adv. Funct. Mater. 2015, 25:384-392.
122. Fang W., Tang S., Liu P., Fang X., Gong J., Zheng N. Pd nanosheet-covered hollow mesoporous silica nanoparticles as a platform for the chemo-photothermal treatment of cancer cells. Small 2012, 8:3816-3822.
123. Bai J., Liu Y., Jiang X. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy. Biomaterials 2014, 35:5805-5813.
124. Moon H.K., Lee S.H., Choi H.C. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009, 3:3707-3713.
125. Ma X., Tao H., Yang K., Feng L., Cheng L., Shi X., et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res. 2012, 5:199-212.
126. Shen S., Tang H., Zhang X., Ren J., Pang Z., Wang D., et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 2013, 34:3150-3158.
127. Wang C., Xu H., Liang C., Liu Y., Li Z., Yang G., et al. Iron oxide at polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano 2013, 7:6782-6795.
128. Gong H., Cheng L., Xiang J., Xu H., Feng L., Shi X., et al. Near-infrared absorbing polymeric nanoparticles as a versatile drug carrier for cancer combination therapy. Adv. Funct. Mater. 2013, 23:6059-6067.
129. Chen Q., Liang C., Wang C., Liu Z. An imagable and photothermal "Abraxane-like" nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors. Adv. Mater. 2014, 27:903-910.
130. Liu T., Wang C., Cui W., Gong H., Liang C., Shi X., et al. Combined photothermal and photodynamic therapy delivered by PEGylated MoS2 nanosheets. Nanoscale 2014, 6:11219-11225.
131. Feng L., Yang X., Shi X., Tan X., Peng R., Wang J., et al. Polyethylene glycol and polyethylenimine dual-functionalized nano-graphene oxide for photothermally enhanced gene delivery. Small 2013, 9:1989-1997.
132. Terentyuk G., Panfilova E., Khanadeev V., Chumakov D., Genina E., Bashkatov A., et al. Gold nanorods with a hematoporphyrin-loaded silica shell for dual-modality photodynamic and photothermal treatment of tumors in vivo. Nano Res. 2014, 7:325-337.
133. Wang N., Zhao Z., Lv Y., Fan H., Bai H., Meng H., et al. Gold nanorod-photosensitizer conjugate with extracellular pH-driven tumor targeting ability for photothermal/photodynamic therapy. Nano Res. 2014, 7:1291-1301.
134. Gormley A.J., Larson N., Sadekar S., Robinson R., Ray A., Ghandehari H. Guided delivery of polymer therapeutics using plasmonic photothermal therapy. Nano Today 2012, 7:158-167.
135. Park J.-H., von Maltzahn G., Xu M.J., Fogal V., Kotamraju V.R., Ruoslahti E., et al. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc. Natl. Acad. Sci. 2010, 107:981-986.
136. Gormley A.J., Larson N., Banisadr A., Robinson R., Frazier N., Ray A., et al. Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers. J. Controlled Release 2013, 166:130-138.
137. Chen L., Zhong X., Yi X., Huang M., Ning P., Liu T., et al. Radionuclide 131 I labeled reduced graphene oxide for nuclear imaging guided combined radio-and photothermal therapy of cancer. Biomaterials 2015, 66:21-28.
138. Zhou M., Chen Y., Adachi M., Wen X., Erwin B., Mawlawi O., et al. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials 2015, 57:41-49.
139. Song G., Liang C., Gong H., Li M., Zheng X., Cheng L., et al. Core-shell MnSe at Bi2Se3 fabricated via a cation exchange method as novel nanotheranostics for multimodal imaging and synergistic thermoradiotherapy. Adv. Mater. 2015, 10.1002/adma.201503006.
140. Xiao Q., Zheng X., Bu W., Ge W., Zhang S., Chen F., et al. A core/satellite multifunctional nanotheranostic for in vivo imaging and tumor eradication by radiation/photothermal synergistic therapy. J. Am. Chem. Soc. 2013, 135:13041-13048.
141. Yi X., Yang K., Liang C., Zhong X., Ning P., Song G., et al. Imaging-guided combined photothermal and radiotherapy to treat subcutaneous and metastatic tumors using iodine-131-doped copper sulfide nanoparticles. Adv. Funct. Mater. 2015, 25:4689-4699.
142. Wang C., Xu L., Liang C., Xiang J., Peng R., Liu Z. Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv. Mater. 2014, 26:8154-8162.
143. Tao Y., Ju E., Ren J., Qu X. Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy. Biomaterials 2014, 35:9963-9971.
144. Ku G., Zhou M., Song S., Huang Q., Hazle J., Li C. Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. ACS Nano 2012, 6:7489-7496.
145. Arruebo M., Fernández-Pacheco R., Ibarra M.R., Santamaría J. Magnetic nanoparticles for drug delivery. Nano today 2007, 2:22-32.
146. Sun C., Lee J.S., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Delivery Rev. 2008, 60:1252-1265.
147. Thiesen B., Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperth. 2008, 24:467-474.
148. Luo S., Wang L., Ding W., Wang H., Zhou J., Jin H., et al. Clinical trials of magnetic induction hyperthermia for treatment of tumours. OA Cancer 2014, 2:2.
149. Deger S., Schink T., Boehmer D., Taymoorian K., Roigas J., Budach V., et al. Match pair analysis HDR brachytherapy vs. thermoradiotherapy using interstitial thermoseeds. Eur. Urol. 2006, 5(Suppl.):131.
150. Tucker R.D. Use of interstitial temperature self-regulating thermal rods in the treatment of prostate cancer. J. Endourol. 2003, 17:601-607.
151. Deger S., Böhmer D., Türk I., Franke M., Roigas J., Budach V., et al. Thermoradiotherapy with interstitial thermoseeds in treatment of local prostatic carcinoma. Initial results of a phase II study. Der Urologe Ausg A 2001, 40:195-198.
152. Tucke R.D., Platz C.E., Huidobro C., Larson T. Interstitial thermal therapy in patients with localized prostate cancer: histologic analysis. Uro 2002, 60:166-169.
153. Kim D.-H., Nikles D.E., Johnson D.T., Brazel C.S. Heat generation of aqueously dispersed CoFe 2 O 4 nanoparticles as heating agents for magnetically activated drug delivery and hyperthermia. J. Magn. Magn. Mater. 2008, 320:2390-2396.
154. Koning G.A., Eggermont A.M., Lindner L.H., ten Hagen T.L. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm. Res. 2010, 27:1750-1754.
155. Lee J.H., Chen K.J., Noh S.H., Garcia M.A., Wang H., Lin W.Y., et al. On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles. Angew. Chem. Int. Ed. 2013, 125:4480-4484.
156. Freeman M., Arrott A., Watson J. Magnetism in medicine. J. Appl. Phys. 1960, 31:S404-S405.
157. Lübbe A.S., Bergemann C., Riess H., Schriever F., Reichardt P., Possinger K., et al. Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 1996, 56:4686-4693.
158. Li Z., Wang C., Cheng L., Gong H., Yin S., Gong Q., et al. PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy. Biomaterials 2013, 34:9160-9170.
159. Wang C., Sun X., Cheng L., Yin S., Yang G., Li Y., et al. Multifunctional Theranostic Red Blood Cells For Magnetic-Field-Enhanced in vivo Combination Therapy of Cancer. Adv. Mater. 2014, 26:4794-4802.
160. Liu Z., Kiessling F., Gätjens J. Advanced nanomaterials in multimodal imaging: design, functionalization, and biomedical applications. J. Nanomater 2010, 2010:894303.
161. Cosgrove D. Ultrasound contrast agents: An overview. Eur. J. Radiol. 2006, 60:324-330.
162. Xing Z.W., Ke H.T., Wang J.R., Zhao B., Yue X.L., Dai Z.F., et al. Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate. Acta Biomater. 2010, 6:3542-3549.
163. Xing Z.W., Wang J.R., Ke H.T., Zhao B., Yue X.L., Dai Z.F., et al. The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging. Nanotechnol 2010, 21:14.
164. Barnhart J., Levene H., Villapando E., Maniquis J., Fernandez J., Rice S., et al. Characteristics of Albunex: air-filled albumin microspheres for echocardiography contrast enhancement. Invest Radiol. 1990, 25:S162-S164.
165. Smith M.D., Elion J.L., McClure R.R., Kwan O.L., DeMaria A.N. Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. J. Am. Coll. Cardiol. 1989, 13:1622-1628.
166. Forsberg F., Basude R., Liu J.-B., Alessandro J., Shi W.T., Rawool N.M., et al. Effect of filling gases on the backscatter from contrast microbubbles: theory and in vivo measurements. Ultrasound Med. Biol. 1999, 25:1203-1211.
167. El-Sherif D.M., Wheatley M.A. Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J. Biomed. Mater. Res. A 2003, 66A:347-355.
168. Leong-Poi H., Christiansen J., Heppner P., Lewis C.W., Klibanov A.L., Kaul S., et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circ 2005, 111:3248-3254.
169. Arthur Kort I.K. Microbubble formation: In vitro and in vivo observation. J. Clin. Ultrasound 1982, 10:117-120.
170. Blomley M.J.K., Cooke J.C., Unger E.C., Monaghan M.J., Cosgrove D.O. Science, medicine, and the future - Microbubble contrast agents: a new era in ultrasound. Br. Med. J. 2001, 322:1222-1225.
171. Raisinghani A., DeMaria A.N. Physical principles of microbubble ultrasound contrast agents. Am. J. Cardiol. 2002, 90:3J-7J.
172. Ke H.T., Wang J.R., Dai Z.F., Jin Y.S., Qu E.Z., Xing Z.W., et al. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew. Chem. Int. Ed. 2011, 50:3017-3021.
173. Ke H.T., Yue X.L., Wang J.R., Xing S., Zhang Q., Dai Z.F., et al. Gold nanoshelled liquid Perfluorocarbon nanocapsules for combined dual modal ultrasound/CT imaging and photothermal therapy of cancer. Small 2014, 10:1220-1227.
174. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discovery 2005, 4:255-260.
175. Zhou Q.-L., Chen Z.-Y., Wang Y.-X., Yang F., Lin Y., Liao Y.-Y. Ultrasound-mediated local drug and gene delivery using nanocarriers. Biomed. Res. Int. 2014, 2014:13.
176. Lindner J.R. Microbubbles in medical imaging: current applications and future directions. Nat. Rev. Drug Discovery 2004, 3:527-532.
177. Lentacker I., De Smedt S.C., Sanders N.N. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 2009, 5:2161-2170.
178. Pitt W.G., Husseini G.A., Staples B.J. Ultrasonic drug delivery-a general review. Expert Opin. Drug Delivery 2004, 1:37-56.
179. Lammers T., Koczera P., Fokong S., Gremse F., Ehling J., Vogt M., et al. Theranostic USPIO-loaded microbubbles for mediating and monitoring blood-brain barrier permeation. Adv. Funct. Mater. 2015, 25:36-43.
180. Illing R.O., Kennedy J.E., Wu F., ter Haar G.R., Protheroe A.S., Friend P.J., et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br. J. Cancer 2005, 93:890-895.
181. Marmottant P., Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003, 423:153-156.
182. Liang X., Gao J., Jiang L., Luo J., Jing L., Li X., et al. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer. ACS Nano 2015, 9:1280-1293.
183. Rapoport N., Gao Z., Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl. Cancer Inst. 2007, 99:1095-1106.
184. Gao Z., Kennedy A.M., Christensen D.A., Rapoport N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008, 48:260-270.
185. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.-H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Controlled Release 2009, 138:268-276.
186. Yang P., Li D., Jin S., Ding J., Guo J., Shi W., et al. Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. Biomaterials 2014, 35:2079-2088.
187. Rapoport N., Nam K.-H., Gupta R., Gao Z., Mohan P., Payne A., et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J. Controlled Release 2011, 153:4-15.
188. Tong S., Hou S., Zheng Z., Zhou J., Bao G. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett. 2010, 10:4607-4613.
189. Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108:2064-2110.
190. Yoo D., Lee J.H., Shin T.H., Cheon J. Theranostic magnetic nanoparticles. Acc. Chem. Res. 2011, 44:863-874.
191. Yu Y., Sun D. Superparamagnetic iron oxide nanoparticle 'theranostics' for multimodality tumor imaging, gene delivery, targeted drug and prodrug delivery. Expert Rev. Clin. Pharmacol. 2010, 3:117-130.
192. Zou P., Yu Y., Wang Y.A., Zhong Y., Welton A., Galban C., et al. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. Mol. Pharm. 2010, 7:1974-1984.
193. Ghosh D., Lee Y., Thomas S., Kohli A.G., Yun D.S., Belcher A.M., et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat. Nanotechnol. 2012, 7:677-682.
194. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 2007, 13:95-99.
195. Wang C.H., Kang S.T., Yeh C.K. Superparamagnetic iron oxide and drug complex-embedded acoustic droplets for ultrasound targeted theranosis. Biomaterials 2013, 34:1852-1861.
196. Huang H.Y., Hu S.H., Hung S.Y., Chiang C.S., Liu H.L., Chiu T.L., et al. SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy. J. Controlled Release 2013, 172:118-127.
197. Niu D., Wang X., Li Y., Zheng Y., Li F., Chen H., et al. Facile synthesis of magnetite/perfluorocarbon co-loaded organic/inorganic hybrid vesicles for dual-modality ultrasound/magnetic resonance imaging and imaging-guided high-intensity focused ultrasound ablation. Adv. Mater. 2013, 25:2686-2692.
198. Grull H., Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J. Controlled Release 2012, 161:317-327.
199. Deckers R., Moonen C.T. Ultrasound triggered, image guided, local drug delivery. J. Controlled Release 2010, 148:25-33.
200. Bohmer M.R., Chlon C.H., Raju B.I., Chin C.T., Shevchenko T., Klibanov A.L. Focused ultrasound and microbubbles for enhanced extravasation. J. Controlled Release 2010, 148:18-24.
201. Klibanov A.L., Shevchenko T.I., Raju B.I., Seip R., Chin C.T. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. J. Controlled Release 2010, 148:13-17.
202. Yin T.H., Wang P., Li J.G., Zheng R.Q., Zheng B.W., Cheng D., et al. Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas. Biomaterials 2013, 34:4532-4543.
203. Cavalli R., Bisazza A., Trotta M., Argenziano M., Civra A., Donalisio M., et al. New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization. Int. J. Nanomed. 2012, 7:3309-3318.
204. Kong G., Braun R.D., Dewhirst M.W. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res. 2000, 60:4440-4445.
205. Needham D., Dewhirst M.W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv. Drug Delivery Rev. 2001, 53:285-305.
206. Tagami T., Foltz W.D., Ernsting M.J., Lee C.M., Tannock I.F., May J.P., et al. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials 2011, 32:6570-6578.
207. Tagami T., Ernsting M.J., Li S.-D. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J. Controlled Release 2011, 152:303-309.
208. Tagami T., Ernsting M.J., Li S.-D. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. J. Controlled Release 2011, 154:290-297.
209. Zhu L., Huo Z., Wang L., Tong X., Xiao Y., Ni K. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes. Int. J. Pharm. 2009, 370:136-143.
210. Chen K.-J., Chaung E.-Y., Wey S.-P., Lin K.-J., Cheng F., Lin C.-C., et al. Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy. ACS Nano 2014, 8:5105-5115.
211. Goitein M., Jermann M. The relative costs of proton and X-ray radiation therapy. Clin. Oncol. 2003, 15:S37-S50.
212. Roa W., Zhang X., Guo L., Shaw A., Hu X., Xiong Y., et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 2009, 20:375101.
213. Zhang X.-D., Wu D., Shen X., Chen J., Sun Y.-M., Liu P.-X., et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 2012, 33:6408-6419.
214. Korbelik M., Dougherty G.J. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res. 1999, 59:1941-1946.
215. Liu Y., Chen W., Wang S., Joly A.G. Investigation of water-soluble X-ray luminescence nanoparticles for photodynamic activation. Appl. Phys. Lett. 2008, 92:043901.
216. Fajkošová K., Machovcová A., Onder M., Fritz K. Selective radiofrequency therapy as a non-invasive approach for contactless body contouring and circumferential reduction. J. Drugs Dermatol. 2014, 13:291-296.
217. Peng F., Su Y., Ji X., Zhong Y., Wei X., He Y. Doxorubicin-loaded silicon nanowires for the treatment of drug-resistant cancer cells. Biomaterials 2014, 35:5188-5195.
218. Shi J., Wang L., Gao J., Liu Y., Zhang J., Ma R., et al. A fullerene-based multi-functional nanoplatform for cancer theranostic applications. Biomaterials 2014, 35:5771-5784.
219. Rejinold N.S., Jayakumar R., Kim Y.-C. Radio frequency responsive nano-biomaterials for cancer therapy. J. Controlled Release 2015, 204:85-97.
220. Illing R., Kennedy J., Wu F., Ter Haar G., Protheroe A., Friend P., et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br. J. Cancer 2005, 93:890-895.
221. Kong S.D., Zhang W., Lee J.H., Brammer K., Lal R., Karin M., et al. Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release. Nano Lett. 2010, 10:5088-5092.
222. Peiris P.M., Bauer L., Toy R., Tran E., Pansky J., Doolittle E., et al. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano 2012, 6:4157-4168.
223. Sasidharan A., Sivaram A.J., Retnakumari A.P., Chandran P., Malarvizhi G.L., Nair S., et al. Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene. Adv. Healthcare Mater. 2015, 4:679-684.
224. Gannon C.J., Cherukuri P., Yakobson B.I., Cognet L., Kanzius J.S., Kittrell C., et al. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 2007, 110:2654-2665.
225. Bae K.H., Park M., Do M.J., Lee N., Ryu J.H., Kim G.W., et al. Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia. ACS Nano 2012, 6:5266-5273.
226. Books D. Evaluation of hyperthermia effect of magnetic iron oxide nanoparticles coated with different polymers. J. Chem. Eng. Res. 2014, 2:77-84.
227. Glazer E.S., Zhu C., Massey K.L., Thompson C.S., Kaluarachchi W.D., Hamir A.N., et al. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin. Cancer Res. 2010, 16:5712-5721.
228. Ali M.R., Panikkanvalappil S.R., El-Sayed M.A. Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin. J. Am. Chem. Soc. 2014, 136:4464-4467.
229. Karmani L., Bouchat V., Bouzin C., Levêque P., Labar D., Bol A., et al. 89Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy. Nanomedicine 2014, 9:1923-1937.
230. Lee J., Chatterjee D.K., Lee M.H., Krishnan S. Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls. Cancer Lett. 2014, 347:46-53.
231. Liang C., Diao S., Wang C., Gong H., Liu T., Hong G., et al. Tumor metastasis inhibition by imaging-guided photothermal therapy with single-walled carbon nanotubes. Adv. Mater. 2014, 26:5646-5652.
232. Blana A., Murat F.J., Walter B., Thuroff S., Wieland W.F., Chaussy C., et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur. Urol. 2008, 53:1194-1203.
233. Li C.-X., Xu G.-L., Jiang Z.-Y., Li J.-J., Luo G.-Y., Shan H.-B., et al. Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J. Gastroenterol. 2004, 10:2201-2204.
234. Li S.-D., Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 2008, 5:496-504.